| P2093 | author name string | Ming-Chih Chou | |
| | Chih-Yi Chen | |
| | Huei Lee | |
| | Tsang-Chi Lin | |
| | Lung-Hung Tsai | |
| P2860 | cites work | A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1 | Q24338768 |
| | p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy | Q24650994 |
| | p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas | Q27852664 |
| | Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors | Q33384573 |
| | Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays | Q33811487 |
| | PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization | Q34150579 |
| | Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer | Q34436736 |
| | p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. | Q34472383 |
| | Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. | Q34536470 |
| | Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma | Q34696287 |
| | cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma | Q35161430 |
| | The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers | Q35161905 |
| | Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 |
| | High p27 expression is associated with a better prognosis in East Asian non-small cell lung cancer patients | Q37924009 |
| | Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression | Q39085744 |
| | LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas | Q39101598 |
| | ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells | Q40033516 |
| | PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest | Q40702262 |
| | Dual effects of Ral-activated pathways on p27 localization and TGF-β signaling | Q41206555 |
| | Pathway- and expression level-dependent effects of oncogenic N-Ras: p27(Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling | Q42196968 |
| | p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients | Q42748882 |
| | cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer | Q43777713 |
| | Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro | Q48287164 |
| | Prognostic significance of cytoplasmic p27 expression in human melanoma. | Q53112792 |
| | Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer | Q57904929 |
| | Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer | Q59312907 |
| | Formation of p27-CDK complexes during the human mitotic cell cycle | Q71569498 |
| | High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients | Q74513431 |
| | Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer | Q74513452 |
| | Loss of P27Kip1 expression correlates with tumor grade and with reduced disease-free survival in primary superficial bladder cancers | Q77973231 |
| | Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer | Q80859255 |
| P433 | issue | 3 | |
| P304 | page(s) | 4017-4023 | |
| P577 | publication date | 2015-10-20 | |
| P1433 | published in | Tumor Biology | Q15757842 |
| P1476 | title | Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer | |
| P478 | volume | 37 | |